Advertisement

Topics

Amgen Leaps Into the World of Regenerative Medicine With New Investment

19:00 EST 7 Nov 2017 | BioSpace

The proceeds will enable the company to conduct Phase I/IIa clinical trials in Parkinson's Disease and Spinal Cord Injury.

Original Article: Amgen Leaps Into the World of Regenerative Medicine With New Investment

NEXT ARTICLE

More From BioPortfolio on "Amgen Leaps Into the World of Regenerative Medicine With New Investment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...